Animal vaccine sales amount in China was about CNY 7.11 billion (excluding net imports); the sales amount of swine vaccine and poultry vaccines were CNY 3.51 billion and 3.01 billion respectively, accounting for 49.4% and 42.3% of the total sales amount respectively. The market scale of China's animal vaccine is nearly CNY 10 billion in 2012.
Although there are nearly 60 animal vaccine manufacturers in China, the market share is concentrated in the hands of a few corporations. CAHIC, Qingdao Yebio Bioengineering Co. Ltd., Dahuanong, TECON and Chengdu TECBOND are the representatives of China’s animal vaccine industry. The five enterprises accounted for 37.9% of China’s animal vaccine market in the first half of 2012.
Among the key animal vaccine manufacturers in China, China Animal Husbandry Industry Co., Ltd (CAHIC) obtained the highest business income in the first half of 2012—CNY 964 million, accounting for 14.3% market share. TECON, Dahuanong and Jinyu Group also had more than 5% market share respectively. The sales of these companies mainly came from the national mandatory vaccine procurement policy. The proportion of the national mandatory vaccine procurement accounted for 82.7% of CAHIC’s total income in the first half of 2012.
In recent years, animal mandatory immunization coverage is gradually expanded in China. Restricted by the economic conditions, compulsory vaccination epidemics only cover five kinds of animal disease. While there are about 17 kinds of animal diseases; other diseases also have great hazard. With farming enterprises and farmers enhanced emphasis on the prevention and control of animal diseases, the demand of conventional vaccine at their own expense will be further improved in the future. Swine and poultry are the main species in China’s livestock breeding, newcastle disease vaccine and porcine circovirus vaccine will be the two conventional vaccines with very good market prospects.
Buy a copy of this report @ http://www.reportsnreports.com/reports/215143-research-on-chinas-animal-vaccine-industry-2013-2017.html
Report Details:
Published: January 2013
No. of Pages: 85
Price:Single User License:US$2100 Corporate User License:US$3200
Although there are nearly 60 animal vaccine manufacturers in China, the market share is concentrated in the hands of a few corporations. CAHIC, Qingdao Yebio Bioengineering Co. Ltd., Dahuanong, TECON and Chengdu TECBOND are the representatives of China’s animal vaccine industry. The five enterprises accounted for 37.9% of China’s animal vaccine market in the first half of 2012.
Among the key animal vaccine manufacturers in China, China Animal Husbandry Industry Co., Ltd (CAHIC) obtained the highest business income in the first half of 2012—CNY 964 million, accounting for 14.3% market share. TECON, Dahuanong and Jinyu Group also had more than 5% market share respectively. The sales of these companies mainly came from the national mandatory vaccine procurement policy. The proportion of the national mandatory vaccine procurement accounted for 82.7% of CAHIC’s total income in the first half of 2012.
In recent years, animal mandatory immunization coverage is gradually expanded in China. Restricted by the economic conditions, compulsory vaccination epidemics only cover five kinds of animal disease. While there are about 17 kinds of animal diseases; other diseases also have great hazard. With farming enterprises and farmers enhanced emphasis on the prevention and control of animal diseases, the demand of conventional vaccine at their own expense will be further improved in the future. Swine and poultry are the main species in China’s livestock breeding, newcastle disease vaccine and porcine circovirus vaccine will be the two conventional vaccines with very good market prospects.
Buy a copy of this report @ http://www.reportsnreports.com/reports/215143-research-on-chinas-animal-vaccine-industry-2013-2017.html
Report Details:
Published: January 2013
No. of Pages: 85
Price:Single User License:US$2100 Corporate User License:US$3200
Contact sales@reportsandreports.com for
further information.
